Invited Speakers

Dario Farina is Full Professor and Chair in Neurorehabilitation Engineering at the Department of Bioengineering of Imperial College London, UK. At Imperial College, he is also Director of the Network of Excellence in Rehabilitation Technologies, and Director of the Imperial-Meta Wearable Neural Interfaces Research Centre. He has previously been Full Professor at Aalborg University, Aalborg, Denmark, (until 2010) and at the University Medical Center Göttingen, Georg-August University, Germany, where he founded and directed the Department of Neurorehabilitation Systems (2010-2016). Among other awards, he holds a Honorary Doctorate degree in Medicine from Aalborg University, Denmark, and has been the recipient of the IEEE Engineering in Medicine and Biology Society Early Career Achievement Award, the Royal Society Wolfson Research Merit Award, the IEEE EMBS Technical Achievement Award. His research focuses on biomedical signal processing, neurorehabilitation technology, and neural control of movement. Professor Farina has been the President of the International Society of Electrophysiology and Kinesiology (ISEK) (2012-2014) and is currently the Editor-in-Chief of the official Journal of this Society, the Journal of Electromyography and Kinesiology, and an Editor for many other international Journals, including Science Advances and IEEE Transactions on Biomedical Engineering. Professor Farina has been elected Fellow IEEE, AIMBE, ISEK, EAMBES, AAIA, Sigma Xi.

Dr. Ferrara is Professor of Radiology and Division Chief of the Molecular Imaging Program at Stanford University. She previously served as the founding chair of the Department of Biomedical Engineering at UC Davis. Dr. Ferrara is a member of the National Academy of Engineering and a fellow of the American Association for the Advancement of Science, Institute of Electrical and Electronic Engineers, Biomedical Engineering Society, Acoustical Society of America, World Molecular Imaging Society and American Institute of Medical and Biological Engineering. Her publications include more than 320 manuscripts at the intersection of molecular imaging and biology. Her laboratory has received awards that include the IEEE UFFC Achievement Award, the IEEE Ultrasonics Rayleigh Award, the IEEE Biomedical Engineering Award, the WMIC Gold Medal, the Distinguished Investigator Award from the Academy for Radiology and Biomedical Imaging Research, and the Judith Poole Award from the Association of Women in Science. Her contributions include work in ultrasound imaging and therapy and the use of positron emission tomography in therapeutic protocols.

Professor Liselotte Højgaard, MD, DMSc, Liselotte Højgaard is a clinician scientist and specialist in Clinical Physiology & Nuclear Medicine. She was Head of Department of Rigshospitalet’s Department of Clinical Physiology, Nuclear Medicine & PET from 2000 to 2023, a leading clinical PET center in oncology. She is Professor at the University of Copenhagen in medical technology and Adjunct Professor at DTU. Højgaard is member of the Scientific Council of ERC and was previously President of EMRC The European Medical Research Councils, and Chair of the Danish National Research Foundation. She is member of the Board of Directors of the Novo Nordisk Foundation, The Bosch Foundation in Germany, and holds a Knighthood in Denmark and is Chevalier de la légion d’honneur in France. Her research with more than 250 peer review publications focuses on pathophysiology, nuclear medicine, and AI, and she has supervised more than 50 masters and Ph.D. students, the majority from bioengineering. She was co-founder of the cross disciplinary education as bioengineer in medicine and technology established in 2003 between DTU, The Technical University of Denmark, University of Copenhagen and Rigshospitalet.

Jeffrey Hubbell leads an initiative on translational biosciences and bioengineering as New York University’s Vice President of Strategy for Bioengineering. Before moving to New York University, Hubbell was at the University of Chicago in the Pritzker School of Molecular Engineering, where he helped build its strength in immunoengineering. Prior to that, he was on the faculty of the Swiss Federal Institute of Technology Lausanne (EPFL, where he served as founding Director of the Institute of Bioengineering and Dean of the School of Life Sciences), the Swiss Federal Institute of Technology Zurich (ETHZ) and University of Zurich, the California Institute of Technology, and the University of Texas in Austin. He was elected to the US National Academy of Engineering in 2010, the National Academy of Medicine in 2019, the American Academy of Arts and Sciences in 2021, and the National Academy of Sciences in 2023. With more than 400 papers and 100 issued US patents, Hubbell uses biomaterials and protein engineering approaches to investigate topics in regenerative medicine and immunotherapeutics. In regenerative medicine, he develops both materials and protein therapeutics to address issues such as chronic wound healing in diabetes and bone repair after trauma. In immunotherapeutics, he pursues nanomaterials in vaccination for infectious disease and cancer as well as targeted therapy with RNA, protein-material conjugates for inverse vaccines to induce antigen-specific tolerance in autoimmunity and allergy, and in protein therapy to tip immune balances toward aggression in immuno-oncology and toward tolerance in inflammatory disease. His interests are both basic and translational, having founded or co-founded six biomedical companies based on his technology.

Professor Nicholas A. Peppas is a biomedical/chemical engineer, materials scientist, and nanotechnologist whose research contributions, innovations, inventions have led to twenty chemical, medical and pharmaceutical products. Peppas is an elected member of the US-National Academy of Engineering, Academy of Medicine, American Academy of Arts and Sciences, Academy of Inventors, European Academy of Sciences, Academia Europaea, Canadian Engineering Academy, Indian National Engineering Academy, Chinese Academy of Engineering, Korean Academy of Science Technology, National Academy of France, Royal Academy of Spain, Academy of Athens, Greece, Academy of Romanian Scientists, Mexican Academy of Sciences, Academy of Texas, Royal Society of Chemistry (UK) and Italian Society for Medical and Biological Sciences. He has served as a Visiting Professor in the Universities of Geneva, Paris-Sud, Santiago de Compostela, Madrid, Lisbon, Parma, Pavia, Napoli, Hecettepe/Ankara, Athens, Berlin, Hebrew University/Jerusalem, Hoshi University/Tokyo, Nanyang University/Singapore, Sichuan University, Peking Medical College. Peppas is a distinguished professor in Chemical Engineering, Biomedical Engineering, Pediatrics, Surgery and Pharmacy, and a member of the Texas Materials Institute at the University of Texas at Austin. His group has set the fundamentals of flow and transport phenomena in numerous medical problems, based on the principles of engineering science and biology. He has numerous books, 1,850 publications and is cited in more than 225,000 references (H=215). Honored by 190 Awards including NAE Founders Award, NAM Adam Yarmolinsky, Pharmaceutical Global Leader Award, and the Biomaterials Global Impact Awards. Peppas holds a D.Eng. from NTU Athens, a ScD. from MIT and is the recipient of 16 honorary doctorates and professorships from France, Spain (2), Italy, Belgium, Greece (4), Slovenia, Romania, Israel and China (4). He is the Editor of Regenerative Biomaterials (Oxford) and Past-President on the International Sigma Xi organization.

Professor Dame Molly Stevens DBE FRS FREng is the John Black Professor of Bionanoscience at the University of Oxford and a part-time professor at Imperial College London and the Karolinska Institute. Molly’s multidisciplinary research balances the investigation of fundamental science with the development of technology to address some of the major healthcare challenges. She is a serial entrepreneur and the founder of several companies in the diagnostics, advanced therapeutics, and regenerative medicine fields. Her work has been instrumental in elucidating bio-material interfaces. She has created a broad portfolio of designer biomaterials for applications in disease diagnostics and regenerative medicine. Her substantial body of work influences research groups around the world and she has been multiple times listed as Clarivate Analytics Highly Cited Researcher in Cross-Field research. Molly holds numerous leadership positions, Deputy Director of the Kavli Institute for Nanoscience Discovery, Deputy Director of the UK Quantum Biomedical Sensing Research Hub, and Scientist Trustee of the National Gallery. She is a Fellow of the Royal Society and the Royal Academy of Engineering (UK), a Foreign Member of the National Academy of Engineering (USA), an International Honorary Member of the American Academy of Arts and Sciences, and she was recognised with the 2023 Novo Nordisk Prize and the 2024 Royal Society Armourers and Brasiers Company Prize, amongst many other accolades.

Professor David Clifton is the Royal Academy of Engineering Chair of Clinical Machine Learning at the University of Oxford, and leads the Computational Health Informatics (CHI) Lab which focuses on “AI for Healthcare”. He is also NIHR Research Professor, appointed as the first non-medical scientist to the NIHR’s flagship chair. He is OCC Fellow in AI & ML at Reuben College, a Research Fellow of the Royal Academy of Engineering, Fellow of the Alan Turing Institute, Visiting Chair in AI for Health at the University of Manchester, and a Fellow of Fudan University, China. He studied Information Engineering at Oxford’s Department of Engineering Science, supervised by Lord (Lionel) Tarassenko. His previous research resulted in patented systems for jet-engine health monitoring, used with the engines of the Airbus A380, the Boeing 787 “Dreamliner”, and the Eurofighter Typhoon. Since 2008, he has focused mostly on the development of AI-based methods for healthcare. His research has been commercialised via various university spin-out companies and multinational industrial bodies.

Jørgen Arendt Jensen (M’93–SM’02–F’12) received the Master of Science degree in electrical engineering in 1985 and the Ph.D. degree in 1989, both from the Technical University of Denmark. He received the Dr.Techn. degree from the university in 1996. He is since 1993 full Professor of Biomedical Signal Processing with the Department of Health Technology, Technical University of Denmark. He has been head of the Center for Fast Ultrasound Imaging since its inauguration in 1998. Fifty-five PhD students have graduate from CFU. He has published more than 550 journal and conference papers on signal processing and medical ultrasound and the book Estimation of Blood Velocities Using Ultrasound (Cambridge Univ. Press), 1996. He is also the developer and maintainer of the Field II simulation program. He has been a visiting scientist at Duke University, Stanford University, and the University of Illinois at Urbana-Champaign. He is head of the Ultrasound and Biomechanics Section from 2020. In 2003, he was one of the founders of the biomedical engineering program in Medicine and Technology, which is a joint degree program between the Technical University of Denmark and the Faculty of Health and Medical Sciences at the University of Copenhagen. The degree is one of the most sought-after engineering degrees in Denmark. He was chairman of the study board from 2003 to 2010 and Adjunct Professor with the University of Copenhagen from 2005 to 2010. He has given a number of short courses on simulation, synthetic aperture imaging, and flow estimation at international scientific conferences and teaches biomedical signal processing and medical imaging at the Technical University of Denmark. His research is centered around simulation of ultrasound imaging, synthetic aperture imaging, vector blood flow estimation, construction of ultrasound research systems, fast 3-D super resolution imaging, and their clinical translation. Dr. Jensen has given more than 70 invited talks at international meetings and received several awards for his research, most recently the Grand Solutions Prize from the Danish Minister of Science, the order of Dannebrog by her Majesty the Queen of Denmark, the Rayleigh award from the IEEE UFFC, and the prestigious Synergy grant from the European Research Council ERC.

Dr. Wu is the Lam Woo and Chair Professor of Biomedical Engineering at the University of Hong Kong. He obtained his BEng in Instrumentation Engineering from Tianjin University in 1984, MSc in Medical Physics from University of Wisconsin – Madison in 1988, and PhD in Radiological Sciences from University of California – Irvine in 1993. From 1990 to 2003, Dr. Wu worked in Columbia University first as an Assistant Professor and later as an Associate Professor of Radiology and Biomedical Engineering. Dr. Wu joined the University of Hong Kong in 2003. At present, his primary research focus is to re-engineer MRI systems for wider healthcare applications through computing, as well as to develop fMRI methodologies for probing brain circuits by combing MRI with electrophysiology and emerging neuromodulation approaches such as optogenetics. Dr. Wu is an elected Fellow of ISMRM, IEEE, and AIMBE. Dr. Wu is the Asia-Pacific Editor of NMR in Biomedicine (NBM) since 2011 and Editorial Board Member of Magnetic Resonance in Medicine (MRM).

Anja Boisen is head of section and professor at department of Health Technology, Technical University of Denmark. Also, she is heading a DNRF and Villum Centre of Excellence named ‘IDUN – Intelligent Drug Delivery and Sensing Using Microcontainers and Nanomechanics’. Her research group focuses on the development and application of nano-sensors, energy harvesting in the body and ingestible devices for sensing, sampling and delivery. Anja is cofounder of companies Cantion, Silmeco BluSense Diagnostics and LightNovo. She is, among others, member of the board of the Leo Foundation, the board of Villum Foundation, the Danish Academy of the Technical Sciences, and the Royal Danish Academy of Sciences. In 2008 she was awarded the largest research prize in Denmark, the Villum Kann Rasmussen award and in 2012 she was awarded the EliteForsk Award from the Danish ministry of Research, Innovation and Higher Education. In 2013 she received the ‘Sapere Aude – top researcher award’ from the Danish Council for Independent Research. Recently, in 2020 she was awarded the Order of Dannebrog by her Majesty the Queen of Denmark. In 2021 she was elected fellow of the electrochemical society (ECS) and became MNE 2021 fellow at the annual international conference on Micro and Nano Engineering (MNE). In 2022 she received the ECS outstanding Achievement Award. She has received two ERC advanced grants (2013 & 2022) and three ERC POC grants.

Massimo De Vittorio is Full Professor at the Technical University of Denmark. He is also principal investigator at the Center for Biomolecular Nanotechnologies of the Istituto Italiano di Tecnologia (Lecce – Italy), where he has served as Center Director for the past ten years. In his career, he has developed novel micro and nano technologies applied to ICT, energy, and life science and he has designed and coordinated micro and nanofabrication facilities with full prototyping and small/medium scale production capabilities. He is currently focusing his research on nanomachined implantable probes for manipulating and recording brain activity and on piezoelectric transducers applied to wearable and skin sensors and ingestible sensors for monitoring and controlling pathophysiological signals and symptoms in real-time. He is co-author of about 460 manuscripts in international journals, 14 patents, 10 book chapters, and several invited/keynote talks at international conferences. He has served on several boards and committees, and for his activity, he has received recognition and awards. He is the recipient of the 2023 Novo Nordisk Foundation Research Laureate Award and of the 2024 Fellow Award of the International Micro and Nano Engineering Society (iMNEs).

Professor Adil Mardinoglu works as a Professor of Systems Biology at the Centre for Host-Microbiome Interactions at King’s College London, UK, and Science for Life Laboratory (SciLifeLab) at KTH-Royal Institute of Technology in Sweden. At the helm of a 20-strong research team, Professor Mardinoglu spearheads the development of novel treatment strategies for metabolic and neurodegenerative diseases, as well as certain cancers, blending multiomics, systems biology, AI and experimental biology with drug development. A key contributor to the Swedish Human Protein Atlas program, Professor Mardinoglu has aided in the construction of a comprehensive human tissue, subcellular, and pathology atlas, and he has been instrumental in developing the cell atlas within the international Human Cell Atlas initiative. His scholarly output includes around more than 250 research and review articles published in journals such as Science, Nature, Nature Biotechnology, Cell Metabolism, Nature Metabolism, Nature Communications, PNAS, Cell Reports, Molecular Systems Biology, and EbioMedicine. Furthermore, as a co-founder of SZA Longevity, BASH Biotech, ScandiBio Therapeutics, ScandiEdge Therapeutics, and Trustlife Therapeutics, he has made substantial entrepreneurial contributions to the biotech sector.

Professor Poul Jennum completed MD from University of Copenhagen 1983, he passed a degree of scientific excellence in 1985, a doctoral thesis from 1998, and he obtained specialties in clinical neurophysiology, neurology and European accreditation in sleep medicine. Professor Jennum is heading the national sleep center and holds several national and international board positions (ESRS, EAN etc), advisory function for the national health board among others. Professor Jennum holds a large national research group focusing on clinical, neurophysiological, advanced data science methods, and molecular sleep and neurological research. Professor Jennum has published more than 480 peer reviewed paper and several teaching books and chapters and has more than 1000 international presentations and conference papers.

Richard L. Lieber, Ph.D. Professor and Chief Scientific Officer Shirley Ryan Ability Lab Departments of Physical Medicine & Rehabilitation and Biomedical Engineering Northwestern University, Chicago, IL 60611 Senior Research Career Scientist Hines VA Medical Center, Hines IL 60141 Rick Lieber is a physiologist who earned his Ph.D. in Biophysics from U.C. Davis developing a theory of light diffraction that was applied to mechanical studies of single muscle cells. He joined the faculty at the University of California, San Diego in 1985 where he spent the first 30+ years of his academic career, achieving the rank of Professor and Vice-Chair of the Department of Orthopaedic Surgery. He received his M.B.A. in 2013 and is currently Chief Scientific Officer and Senior Vice President at the Shirley Ryan AbilityLab (formerly Rehabilitation Institute of Chicago) and Professor of Physical Medicine & Rehabilitation, Physiology and Biomedical Engineering at Northwestern University in Chicago, IL. Dr. Lieber’s work represents a translational approach, applying basic scientific principles to help patients who have experienced spinal cord injury, stroke, musculoskeletal trauma and cerebral palsy —an approach that is relevant to those who study biomechanics, rehabilitation and orthopaedic surgery. He has published over 350 articles in journals ranging from the very basic such as The Biophysical Journal, Journal of Cell Science and The Journal of Cell Biology to clinical journals such as The Journal of Hand Surgery and Clinical Orthopaedics and Related Research. Dr. Lieber’s research focuses on design and plasticity of skeletal muscle. Currently, he is developing state-of-the-art biological and biophysical approaches to understanding muscle contractures that result from cerebral palsy, stroke and spinal cord injury. In recognition of the clinical impact of his basic science studies, Dr. Lieber has been honored by the Department of Veterans Affairs (Paul B. Magnuson Award), the Elsass Foundation (Research in CP Award), American Academy of Orthopaedic Surgeons (Kappa Delta Award; twice), the American Bone and Joint Surgeons (Nicolas Andry Award) the American College of Sports Medicine (Fellow), the Council for the International Exchange of Scholars (Fulbright Fellowship) and the American Society for Biomechanics (Borelli Award; Hay Award; Fellow) and the American Institute for Medical and Biological Engineering (AIMBE; Fellow). He was also named a Senior Research Career Scientist from the Department of Veterans Affairs from which he has received continuous support since 1985.

Abdelsalam Ali Helal (aka: Sumi Helal) is a Professor in the Computer Science and Engineering Department at the University of Bologna, Italy. Prior to joining the University of Bologna, he spent 26 years as associate and then full processor in the Computer & Information Science and Engineering Department at the University of Florida, USA. At University of Florida, he directed the Mobile and Pervasive Computing Laboratory, co-founded and directed the Gator Tech Smart House –a real-world deployment project that aimed at identifying key barriers and opportunities to make the Smart Home concept a common place (creating the “Smart Home in a Box” concept). His active areas of research focus on architectural and programmability aspects of the Internet of Things (IoT), service-oriented IoT architectures, IoT edge intelligence, and pervasive/ubiquitous systems and their human-centric applications, especially in the Digital Health area. Helal is also a technologist at heart who founded several successful ventures in the areas of IoT and Digital Health. His patents that came out of his research were licensed by the top multinational tech industry including Google, Apple, Samsung, Bosch, Siemens, T-Mobile, Verizon, AT&T among others. Helal is a Fellow of the ACM, IEEE, AAAS, AAIA, IET, and a member of Academia Europaea. He can be contacted at: helal@acm.org

Walter Karlen, Ph.D., is a Professor of Biomedical Engineering and the Director of the Institute of Biomedical Engineering at Ulm University, Germany. He holds an M.Sc. in Micro-Engineering and a Ph.D. in Computer, Communication, and Information Sciences from EPF Lausanne, Switzerland. From 2009 to 2014, Professor Karlen conducted postdoctoral research with the Electrical and Computer Engineering in Medicine group at the University of British Columbia (UBC), Canada, and the Biomedical Engineering Research Group at Stellenbosch University, South Africa. Between 2014 and 2020, he led the Mobile Health Systems Lab at ETH Zürich, Switzerland. Professor Karlen has received numerous accolades, including the Rising Stars in Global Health award from Grand Challenges Canada (2012), a Killam Postdoctoral Fellowship at UBC (2013), and a prestigious Swiss National Science Foundation (SNSF) Professorship (2014). He currently co-directs the flagship “SleepLoop” project at University Medicine Zurich, which aims on developing and validating innovative technologies to enhance sleep quality. He is a Senior Member of the IEEE Engineering in Medicine and Biology Society (EMBS) and active member of the German Society for Biomedical Engineering (DGBMT) of VDE. Professor Karlen’s research focuses on the full-stack development of autonomous medical wearables for the remote management and treatment of acute and chronic diseases. His work spans real-time biomedical signal processing, machine learning, mobile computing, sensor and systems design, physiological and data-driven modeling, and clinical validation.

Katja Mombaur joined the Karlsruhe Institute of Technology in Germany in 2023 as Full Professor, Chair for Optimization & Biomechanics for Human-Centred Robotics and Director of the BioRobotics Lab. In addition, she holds an affiliation with the University Waterloo in Canada where she has been Full Professor and Canada Excellence Research Chair (CERC) for Human-Centred Robotics & Machine Intelligence since 2020. Prior to moving to Canada, she has been a Full Professor at Heidelberg University where she directed the Optimization, Robotics & Biomechanics Chair, as well as the Heidelberg Center for Motion Research. Her international experience includes research activities at LAAS-CNRS in Toulouse and Seoul National University, as well as in the USA. She studied Aerospace Engineering at the University of Stuttgart and SupAéro and holds a PhD in Mathematics from Heidelberg University. Katja Mombaur currently serves as the Vice President for Member Activities of the IEEE Robotics & Automation Society and as Senior Editor of the IEEE Transactions on Robotics. Katja’s research focuses on understanding human movement by a combined approach of model-based optimization and experiments and using this knowledge to improve motions of humanoid robots and the interactions of humans with exoskeletons, prostheses, and external physical devices. Her goal is to endow humanoid and wearable robots with motion intelligence that allows them to operate safely in a complex human world. The development of efficient algorithms for motion generation, control, and learning is a core component of her research.

Levi J. Hargrove, PhD, P.Eng, earned his MScE and PhD in Electrical Engineering from the University of New Brunswick in 2005 and 2008, respectively. He is currently the Director and Scientific Chair of the Center for Bionic Medicine at the Shirley Ryan AbilityLab and an Associate Professor in the Departments of Physical Medicine & Rehabilitation and the McCormick School of Engineering at Northwestern University. As a leading figure in the prosthetics industry, Dr. Hargrove oversees a research portfolio valued at approximately $25M USD, which encompasses cutting-edge projects aimed at developing clinically-realizable myoelectric control systems for individuals with limb loss. With over 200 peer-reviewed articles published in a variety of high-impact journals, Dr. Hargrove is widely regarded as a respected thought leader in the field. Dr. Hargrove’s key projects include developing advanced and adaptive control systems for bionic legs, improving the control of robotic hand prostheses, and evaluating intramuscular EMG signals collected using biocompatible implants. In 2012, he co-founded Coapt, a company that has successfully translated machine-learning-based prosthetic limb controllers. The company has sold over a thousand systems to amputees worldwide, helping them regain their independence and improve their quality of life.

Axel Thielscher obtained doctoral degrees in Electrical Engineering and Biomedical Sciences, both “with highest honor”, from the University of Ulm (Germany). This was followed by a PostDoc stay at Brown University (Providence, RI) and a position as research group leader at the Max-Planck-Institute for Biological Cybernetics (Tübingen, Germany). He moved to Denmark in 2012 where he started on a shared position as Associate Professor at the Technical University of Denmark and Senior Researcher at the Danish Research Centre for Magnetic Resonance (Copenhagen University Hospital Amager & Hvidovre), before being promoted to Full Professor in 2021.

Jakob E. Bardram, MSc, PhD in computer science, is a professor at the Department of Health Technology at the Technical University of Denmark and the head of the Digital Health research section. His main research areas are software architecture, mobile & ubiquitous computing, and human-computer interaction. His research focuses on applications within healthcare, ranging from interactive displays for clinical logistics in hospitals to digital phenotyping in psychiatry, neurology, cardiology, and diabetes. He is the principal software architect of the Copenhagen Research Platform (CARP) for digital phenotyping and the CARP Mobile Sensing framework for mobile and wearable sensing. He is also an active entrepreneur and is the co-founder of Cetrea and Monsenso, where he has served as a board member and in different C-level roles, including CEO and CTO. Read more about CARP at carp.dk and about Jakob on his home page, www.bardram.net.

Professor, Consultant Ismail Gögenur Ismail Gögenur is the founder and leader of Center for Surgical Science, a multidisciplinary research unit consisting of molecular biologists, data scientists, bioinformaticians and clinical researchers involved in translational research, clinical research (including multi-center international trials) and Big Data methodologies. He has more than 500 scientific articles published in national and interna-tional peer-reviewed medical journals. His overarching research focus is within the development and implementation of new surgical treatments and on surgical pathophysiology.

Matt Brookes is a Professor of Physics at the University of Nottingham, UK. His work centres on development and application of multi-modal brain imaging, particularly MEG where over the last 20 years his group has made significant contributions to inverse modelling, connectivity measurement, clinical applications and development of MEG hardware using quantum technologies. Brookes was the recipient of a Blavatnik Laureate award in physical sciences and engineering in 2022, and an OBE for services to physics in 2024.

I studied chemistry at Vienna University where I obtained my PhD in 2009. During my PhD I studied biology in addition before I went on to do a postdoc at Stanford University and ETH Zurich. In 2014 I started my own group at Groningen University at the University Medical Center Groningen. Her I am leading a research group which is developing nanoscale MRI techniques which allow nanoscale sensing in living cells. In the past years I have been awarded several grants and awards including a European ERC starting grant and its Dutch equivalent the VIDI